1. Ponatinib and blinatumomab for Philadelphia chromosome-positive acute lymphoblastic leukaemia: a US, single-centre, single-arm, phase 2 trial. Issue 1 (January 2023) Authors: Jabbour, Elias; Short, Nicholas J; Jain, Nitin; Huang, Xuelin; Montalban-Bravo, Guillermo; Banerjee, Pinaki; Rezvani, Katayoun; Jiang, Xianli; Kim, Kun Hee; Kanagal-Shamanna, Rashmi; Khoury, Joseph D; Patel, Keyur; Kadia, Tapan M; Daver, Naval; Chien, Kelly; Alvarado, Yesid; Garcia-Manero, Guille... Journal: Lancet Issue: Volume 10:Issue 1(2023) Page Start: e24 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗